Vanguard Group Inc Unity Biotechnology, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.4 - $4.27 $1.26 Million - $13.5 Million	3,155,586 Added 246.21%	4,437,259 $1.75 Million
Q2 2022 Aug 12, 2022	BUY	$0.56 - $1.29 $87,627 - $201,856	156,478 Added 13.91%	1,281,673 $723,000
Q1 2022 May 13, 2022	SELL	$0.72 - $1.86 $470,602 - $1.22 Million	-653,614 Reduced 36.74%	1,125,195 $1.26 Million
Q4 2021 Feb 14, 2022	BUY	$1.3 - $3.17 $480,259 - $1.17 Million	369,430 Added 26.21%	1,778,809 $2.6 Million
Q3 2021 Nov 12, 2021	SELL	$2.91 - $4.5 $24,892 - $38,493	-8,554 Reduced 0.6%	1,409,379 $4.23 Million
Q2 2021 Aug 13, 2021	BUY	$4.15 - $6.3 $5.88 Million - $8.93 Million	1,417,933 New	1,417,933 $6.58 Million

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $20.6M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.